JBIO compared with ELVN: revenue, margins and what each company keeps, and the suppliers and customers both name

JBIOJade Biosciences, Inc.

Mkt capRevenueRevenue

ELVNEnliven Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

JBIOJade Biosciences, Inc.

ELVNEnliven Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

JBIOJade Biosciences, Inc.

14.07▼−1.19%· post 14.07

Mkt cap$894.2M

ELVNEnliven Therapeutics, Inc.

44.25▼−1.83%· post 44.25

ClosedOct 30 '26

Mkt cap$3.2B

Compare

ClosedOct 30 '26

JBIOJade Biosciences, Inc.

ELVNEnliven Therapeutics, Inc.

14.07▼−1.19%post 14.07

Price

44.25▼−1.83%post 44.25

$894.2M

Mkt cap

$3.2B

JBIO14.07▼−1.19%vsELVN44.25▼−1.83%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

JBIO, solidELVN, dashed

Supply-chain overlap

Revenue flow

JBIO: latest quarter not drawable. ELVN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only JBIO 3

—Patheon Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

—WuXi Biologics Irelandunlistedsupplier

Shared 0

No shared counterparties.

Only ELVN 5

—CoreRxunlistedsupplier

—Hande Sciencesunlistedsupplier

—Latitude Pharmaceuticalsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Pharmaron

unlistedsupplier

1 more · ELVN chain ›